Showing results 1 to 20 of 69
next >
| Issue Date | Title | Author(s) |
| Sep-2016 | A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions | Darbà, Josep; Ramírez, Gabriela; García-Rivero, Juan L.; Mayoralas, Sagrario; Pascual, José Francisco; Roger, Albert; Vargas, Diego; Bijedic, Adi |
| Jan-2021 | A discrete choice experiment to understand preferences of patients with type 2 diabetes treated with injectable non-insulinic agents | Darbà, Josep; Ascanio, Meritxell |
| Apr-2019 | Admissions and Cost of Hospitalisation of Phenylketonuria: Spanish Claims Database Analysis | Darbà, Josep; Ascanio, Meritxell |
| 26-May-2022 | Ambulatory and hospital care of glaucoma in Spain and associated medical costs | Darbà, Josep; Marsà, Alícia |
| 4-May-2021 | Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018) | Darbà, Josep; Marsà, Alícia |
| 13-Feb-2020 | Analysis of the management and costs of headache disorders in Spain during the period 2011-2016: a retrospective multicentre observational study | Darbà, Josep; Marsà, Alícia |
| 1-Jun-2025 | Assessing a decade of leukaemia-related premature mortality costs:impact on productivity loss in Spain | Darbà, Josep; Ascanio, Meritxell; Agüera, Ainoa |
| Jul-2021 | Atopic dermatitis in specialized centers in Spain: a retrospective analysis of incidence and costs (2000-2017) | Darbà, Josep; Marsà, Alícia |
| Sep-2018 | Budget impact analysis of oral Fisiogen Ferro Forte versus intravenous iron for the management of iron deficiency in chronic kidney disease in Spain | Darbà, Josep; Ascanio, Meritxell |
| Jan-2021 | Burden of Hodgkin and non-Hodgkin lymphoma in Spain over a 10-year period: productivity losses due to premature mortality | Darbà, Josep; Marsà, Alícia |
| 1-Oct-2022 | Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care | Darbà, Josep; Marsà, Alícia |
| Oct-2019 | Characteristics, comorbidities, and use of healthcare resources of patients with phenylketonuria: a population-based study | Darbà, Josep |
| 5-Feb-2020 | Characteristics, management and medical costs of patients with depressive disorders admitted in primary and specialised care centres in Spain between 2011 and 2016 | Darbà, Josep; Marsà, Alícia |
| 28-Oct-2021 | Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs | Darbà, Josep; Marsà, Alícia |
| Dec-2020 | Chronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011-2017) | Darbà, Josep; Marsà, Alícia |
| 7-Jan-2025 | Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal study | MacGowan, Guy; Charman, Sarah Jane; Okwose, Nduka C; Groenewegen, Amy; Del Franco, Annamaria; Tafelmeier, Maria; Preveden, Andrej; Garcia Sebastian, Cristina; Fuller, Amy S; Sinclair, David; Edwards, Duncan; Nelissen, Anne Pauline; Malitas, Petros; Zisaki, Aikaterini; Darbà, Josep; Bosnic, Zoran; Vracar, Petar; Barlocco, Fausto; Fotiadis, Dimitris; Banerjee, Prithwish |
| Feb-2019 | Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin | Sicras Mainar, Antoni; Rejas, Javier; Pérez-Paramo, Maria; Sánchez-Álvarez, Luis; Navarro-Artieda, Ruth; Darbà, Josep |
| Nov-2017 | Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus - from the Spanish National Health System perspective | Mezquita-Raya, Pedro; Darbà, Josep; Ascanio, Meritxell; Ramírez de Arellano, Antonio |
| 20-Dec-2019 | Cost-effectiveness of insulin degludec versus insulin glargine U100 in patients with type 1 and type 2 diabetes in Portugal: evidence from SWITCH 1&2 trials | Darbà, Josep; Ascanio, Meritxell; Carvalho, Davide; Conde, Vasco; Pedersen, Kasper S. |
| Feb-2015 | Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain | Darbà, Josep; Kaskens, Lisette; Sorio Vilela, Francesc; Lothgren, Mickael |
